BioLife Solutions BLFS Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net?
- BioLife Solutions (BLFS) reported debt - unamortized discount (premium) and issuance costs, net of $1K in Q1 2026.
- How has BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net decreased by 96.0% year-over-year, from $25K to $1K.
- What is the long-term trend for BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net?
- Over 3 years (2022 to 2025), BioLife Solutions's debt - unamortized discount (premium) and issuance costs, net has grown at a -74.4% compound annual growth rate (CAGR), from $179K to $3K.
- What does debt - unamortized discount (premium) and issuance costs, net mean?
- This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.